key: cord-0700328-jezkk6st
authors: Li, Jing; Wu, Ya-Nan; Zhang, Sen; Kang, Xiao-Ping; Jiang, Tao
title: Deep learning based on biologically interpretable genome representation predicts two types of human adaptation of SARS-CoV-2 variants
date: 2022-03-02
journal: Brief Bioinform
DOI: 10.1093/bib/bbac036
sha: 8b266a6e8e75b5f1b79ceb6f91d8d449293bf2a3
doc_id: 700328
cord_uid: jezkk6st

Explosively emerging SARS-CoV-2 variants challenge current nomenclature schemes based on genetic diversity and biological significance. Genomic composition-based machine learning methods have recently performed well in identifying phenotype–genotype relationships. We introduced a framework involving dinucleotide (DNT) composition representation (DCR) to parse the general human adaptation of RNA viruses and applied a three-dimensional convolutional neural network (3D CNN) analysis to learn the human adaptation of other existing coronaviruses (CoVs) and predict the adaptation of SARS-CoV-2 variants of concern (VOCs). A markedly separable, linear DCR distribution was observed in two major genes—receptor-binding glycoprotein and RNA-dependent RNA polymerase (RdRp)—of six families of single-stranded (ssRNA) viruses. Additionally, there was a general host-specific distribution of both the spike proteins and RdRps of CoVs. The 3D CNN based on spike DCR predicted a dominant type II adaptation of most Beta, Delta and Omicron VOCs, with high transmissibility and low pathogenicity. Type I adaptation with opposite transmissibility and pathogenicity was predicted for SARS-CoV-2 Alpha VOCs (77%) and Kappa variants of interest (58%). The identified adaptive determinants included D1118H and A570D mutations and local DNTs. Thus, the 3D CNN model based on DCR features predicts SARS-CoV-2, a major type II human adaptation and is qualified to predict variant adaptation in real time, facilitating the risk-assessment of emerging SARS-CoV-2 variants and COVID-19 control.

The sporadic zoonotic transfer of a pathogen may cause human disease and even death but does not necessarily cause sustained human-to-human transmissibility (e.g. Ebola and Hanta viruses); only human-adapted pathogens, such as human-transmissible coronaviruses (CoVs) and inf luenza A viruses (IAVs), cause sustained transmission in populations and pandemics [1, 2] . Human-infective, bat-originating CoVs [3] , such as the highly pathogenic severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) CoVs, only resulted in regional, passing outbreaks [4] , indicating limited human adaptation. In contrast, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1 are globally transmissible, causing 15-30% of common cold cases every year [5] thus, they are more human-adapted (type II human adaptation). Taking the transmissibility and pathogenicity of CoVs into account, we defined two types of human adaptation: type I adaptation (SARS and MERS), characterized by higher pathogenicity and lower transmissibility in the population; and type II adaptation (HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1), characterized by lower pathogenicity but higher transmissibility. Since 2019, SARS-CoV-2 [6] has caused a global COVID-19 pandemic (https://covid19. who.int) characterized by high human adaptation [7] [8] [9] [10] [11] . Emerging SARS-CoV-2 variants have presented more worrisome epidemic-promoting advantages [7, [10] [11] [12] , possibly due to faster optimization under vaccination selection pressure [13, 14] . Thus, there is a need to address fundamental questions related to CoV adaptation and discriminate adaptive types of emerging SARS-CoV-2 variants.

Two current nomenclature schemes facilitate the recognition of epidemiological outbreak links based on genetic diversity [15] , and reliably indicate the biological significance of specific variants, which are designated as either variant of interest (VOI) or variant of concern (VOC), based on the expert monitoring of significant amino acid substitutions by the WHO (https://www.who. int/en/activities/tracking-SARS-CoV-2-variants/). However, neither scheme can rapidly assess the risk of any emerging SARS-CoV-2 variant. Research has indicated a contribution of specialized virus-host receptor binding and avidity to interspecies transmission, mainly related to the CoV spike (S) glycoprotein [16] . Many VOC mutations in SARS-CoV-2 S have been shown to promote transmission, enhance receptor binding affinity [9] and antagonize immune escape [11] . However, these ex postexperimental methods are not qualified to assess the adaptation of each SARS-CoV-2 variant in real time.

Sequence compositions of nucleic acids and proteins are significantly associated with genome evolution and adaptation across all kingdoms of life [17] . Machine/deep learning methods have worked well in predicting viral hosts based on the amino acid [18] or dinucleotide (DNT) [19] composition in the sequence alignment of large datasets [20] . Moreover, language representation methods have learned the language of viral evolution and escape based on represented amino acids [21] or statistically represented proteins [22] . Here, we aimed to design a novel method of dinucleotide composition representation (DCR) to learn the general human adaptation of CoVs and build an adaptation predictor for SARS-CoV-2 variants. DCR was first assessed as a classification trait based on the two major viral proteins-receptorbinding glycoprotein (Gp; also named as S for CoVs) and RNA-dependent RNA polymerase (RdRp)-of six single-stranded (ssRNA) orders/families. We evaluated the possible general adaptation of both Gp and RdRp and the representativeness of DCR as a general genomic nucleotide composition trait for DNTs, codons, codon pairs and amino acids (AA). Finally, we built a threedimensional convolutional neural network (3D-CNN) predictor based on DCR to predict the human adaptation of SARS-CoV-2 variants. Our study provides a novel, simplified and reliable genome representation as well as a framework to discern the general human adaptation of SARS-CoV-2, CoVs in general and other emerging viruses.

As shown in the architecture diagram (Figure 1 ), six ssRNA virus families, Bunyaviridae, Orthomyxoviridae, Filoviridae, Flaviviridae, Togaviridae and Coronaviridae, were included in the analysis of the general separability and linearity of the nucleotide d-traits of DNT, DCR, AA, codons and codon pairs in the viral genome ( Figure 1A ). Gp and RdRp were targeted to decompose these traits. Coronaviridae sequences, excluding SARS-CoV-2, were randomly split into training and validation datasets to build an adaptation classifier to predict the human adaptation of the test dataset of SARS-CoV-2 variants. The DCR algorithm was a fine-grained version of compositional DNT embedding [19] , representing the local nucleotide context in a sequence ( Figure 1B ). Six channels of DCR were set to represent six types of DNT pairs ( Figure 1C ). The unsupervised projection methods of t-distributed stochastic neighbour embedding (t-SNE) [23] and principal component analysis (PCA) [24] were utilized to learn the multigrained separability and linearity of randomly sampled CoVs and other RNA viruses ( Figure 1D ). A 3D-CNN framework for threecategory adaptation classification-inadaptation, type I human adaptation and type II human adaptationwas built with three layers of convolution + ReLU, two average pooling layers + one maximum pooling layer, two fully connected layers and a final softmax layer, to predict the human adaptation of each SARS-CoV-2 variant ( Figure 1E ). Temporal and special shifts of SARS-CoV-2 adaptation were further analysed ( Figure 1F ); DCR features that are important for the human adaptation of SARS-CoV-2 were assessed by orthogonality in the DCR vector ( Figure 1G ). Synthetic Minority Over-sampling Technique resampling was implemented to rectify the amount of imbalance among different host-originated samples (Additional file 1: Supplementary Tables S1 and S2, Additional file 2: Supplementary Figure S1 available online at http://bib.oxfordjournals.org/).

To assess the host adaptation of coronaviruses as well as the possibility of predicting human adaptation based on DCR, we first analysed the general separability and linearity of DNT, DCR and other compositional traits in the six families of ssRNA viruses. The two-dimensional t-SNE or PCA projection of these features of 200 randomly sampled Gp and RdRp sequences (Supplementary Table  S2 available Figure  S3 available online at http://bib.oxfordjournals.org/). Further evaluation of data linearity was performed to reflect its continuity and differentiability, and support the machine/deep learning classification of these samples [25] . The linearity feature was designed as the ratio of the data range of PCA1 to the data range of PCA2 based on the orthogonal distribution between PCA1 and PCA2. A higher relative linear distribution (linearity value of PCA1/PCA2 > 1) was obtained for DNTs, codons and DCRs of the six families of viruses for both RdRp ( Figure 2C ) and Gp ( Figure 2D ). In particular, DCR linearity was highest for Gp and the second highest for RdRp among the CoVs, indicating an obvious intraviridae linear distribution. A regression plot reconfirmed the linearity of DNTs ( Figure 2E ) and DCRs ( Figure 2F 

Host-specific or host adaptation-related compositional features in the genome have been observed for various types of RNA viruses at both the nucleic acid [19] and protein levels [18, 21] . We assumed that a genomic compositional adaptation feature would be generally projected in all coding regions or genes of a virus if it existed. Surprisingly, the PCA1 values of DNTs, DCRs ( Figure 3A and B), codons and codon pairs (Additional file 2: Supplementary Figure S6A and B available online at http://bib.oxfordjournals.org/) of S and RdRp were similarly distributed in a two-dimensional view, with clear separation of coronaviruses and different labels of hosts or lineages for sampled human coronaviruses, but this was not observed for the AA trait ( Figure 3C ). A general, strong and positive Spearman correlation was observed in the PCA-reduced component of DNTs ( Figure 3A ) and DCRs ( Figure 3B ) between CoV S and RdRp among five randomly sampled coronaviruses ( Figure 3D ), but this was not found for AA ( Figure 3C ). A similar correlation was observed for the traits of codons and codon pairs ( Figure 3D ). Additionally, the representativeness of the DCR for the other four traits was evaluated; using the R 2 score for the linear regression of other traits against DCR, it was shown that DNTs, codons, codon pairs and AA were highly dependent on DCRs for both S and RdRp ( Figure 3E and F). Thus, we selected DCR as the most representative compositional feature for parsing host adaptation in the coronavirus genome.

Based on the separability and linearity in the DCR of S for CoVs and the representativeness of the DCR of genomic compositional traits, we built a CNN classifier to identify human adaptation within the S genes (three adaptation labels, 1, 2 and 0, indicating type I, type II adaptation and inadaptive, respectively) of SARS-CoV-2 variants based on 3D DCRs ( Figure 1C ). CoVs with type I adaptation (SARS and MERS), CoVs with type II adaptation (HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1) and inadaptive CoVs (Suiformes CoVs) were randomly sampled to learn the model parameters. To visualize the learning curves, 15, 40 or 50 training epochs were performed. Higher error rates were indicated by lower values of the confusion matrix ( Figure 4A ) and the receiver operating characteristic (ROC)-area under the curve (AUC)-ROC ratio ( Figure 4B ) after 15 epochs, along with a sustained high-training loss value ( Figure 4C ). The pair plotting of PCA1 and PCA2 reduced via the PCA method from 768 fully connected layers only indicated a separation between the S samples with type II adaptation and those with type I adaptation/inadaptation ( Figure 4D ). Learning with 40 epochs improved model performance, with a lower error rate for the confusion matrix and ROC/AUC-ROC curve ( Figure 4E and F), and a significant decline in training loss ( Figure 4G ), but without clear separation between inadaptation and type I adaptation ( Figure 4H) . A balanced training result of the separation among three adaptation types ( Figure 4I -K) indicated separation among three types of reduced data and the theoretical temporality of inadaptation, type I adaptation and type II adaptation ( Figure 4L ). Therefore, the trained CNN classifier obtained after 50 epochs was utilized to predict the adaptation of SARS-CoV-2.

Human adaptation was predicted with the 3D-CNN model based on DCRs. All 1 457 628 SARS-CoV-2 S sequences were predicted to show human adaptation of either type I (39.04%) or type II (60.96%). A total of 1 376 088 of the S dataset sequences with complete collection-date information were analysed for temporal and special adaptation shifts. After the observation of a number of sporadic S sequences per month up to November 2020 worldwide, a steep rise in sequences with type I adaptation appeared as of December 2020, peaking at 145 851 in March 2021, predominantly in Europe and North America ( Figure 5A ). The number of sequences with type II adaptation rose to 32 392 in March 2020, which were widely observed in North America, Europe, Asia and Oceania. This number remained fairly steady until September 2020 (approximately 30 000 sequences per month), followed by a steep rising period between October 2020 and March 2021, mainly in North America and Europe ( Figure 5B ). Moreover, sequences with type I adaptation with ratios ranging from 0.15 to 0.44 were labelled VOCs/VOIs from January to May 2020. Starting from October 2020, approximately 10-50% of these sequences were labelled VOCs/VOIs until June 2021. Beginning in December 2020, this set of sequences was increasingly labelled as VOCs/VOIs ( Figure 5C ). A total of 67% of VOC/VOI sequencesmainly Alpha and Kappa-were predicted to show type I adaptation, while 91% of VOIs and 95% of variants other than VOIs and VOCs were predicted to show type II adaptation, indicating consistency in the SARS-CoV-2 risk assessment of the VOC label and type I adaptation ( Figure 5D ). The differences between the other proposed dynamic nomenclature and our model were also analysed. Our results showed that 77% of alpha and 58% of kappa sequences were predicted to show type I adaptation; 88-100% of beta, delta and other sequences were predicted to show type II adaptation ( Figure 5E ). Additionally, the difference in the probability of predicting type I and II adaptation ( -probability, absolute value of probability I minus probability II) was much lower for the S samples showing type I adaptation than for the type II samples ( Figure 5F ). The sampled months of February 2020, December 2020 and June 2021 showed a significant temporal increase in theprobability for the type II samples, compared to the -probability for the type I samples ( Figure 5F ). Taken together, the DCR-based 3D-CNN results predicted a dominant type I human adaptation of SARS-CoV-2 Alpha VOCs, and a dominant type II human adaptation of Beta, Delta and other SARS-CoV-2 variants.

The AA mutations of each SARS-CoV-2 variant have been listed by GISAID (https://www.gisaid.org/). We aimed to analyse the differences in the DNT of each nucleotide site in the S sequence between VOCs and other VOC and VOI variants. A dot product was generated for each DNT vector between the two groups of variants (Additional Table  S5 available online at http://bib.oxfordjournals.org/). The numbers for each type of DNTs in both groups were plotted and marked DNT bias was indicated for each site ( Figure 6B ). Biased DNTs encoding AAs mutations revealed the dominant mutations D1118H, A570D, P681H, S982A, T716I and N501Y ( Figure 6C) . Thus, the 3D-CNN based on DCRs could discriminate the differential DNTs, codons or AAs of sequences with both types of adaptation labels.

The most recent VOC of SARS-CoV-2 B.1.1.529 (Omicron) was first reported to the WHO by South Africa on 24 November 2021 (https://www.who.int/news/ item/26-11-2021-classification-of-omicron-(b.1.1.529)sars-cov-2-variant-of-concern) [26] . Little is known about the transmissibility and pathogenicity of Omicron, which contains many mutations. We performed adaptation prediction of Omicron VOCs to assess their potential transmissibility. A total of 148 of 157 total Omicron S sequences of high quality reported up to 6 December 2021, without any ambiguous nucleotides, were predicted to show type II adaptation (94.27%; Figure 7A ; Additional file 1: Supplementary Table S6 available online at http://bib.oxfordjournals.org/). The Omicron VOC with type II adaptation was first collected (high-quality sequence) on 9 November 2021, in South Africa (HCoV-19/South Africa/NICD-N21437/2021, EPI_ISL_6913991) and has since been found worldwide ( Figure 7B ). The margin score of type II over type I was only 0.0072, although the score difference was statistically significant ( Figure 7C ).

Numerous artificial intelligence frameworks have been developed in different areas of biological inquiry to predict phenotypes from genomic traits. However, the causal relationship between genotype and phenotype has not been seriously considered as a key point for predictor building. Thus, it is vital to find interpretable traits in the genome for phenotype prediction. Several models have been utilized to predict SARS-CoV-2 variants based on viral protein sequences, with a particular focus on key mutant AAs related to receptor binding [ [27] [28] [29] . However, these types of models easily fall into the trap of overfitting and are not suitable for predictions of future possible CoVs other than SARS-CoV-2. The present study aimed to build a more robust model based on general genome features at the viral RNA level. Adaptive determinants have recently been widely identified at the nucleic acid level (genomic DNA,RNA or mRNA) among pathogens such as parasites [30] , bacteria [31] and viruses [18, 19, 32, 33] . The dynamic homeostasis of genomic RNA sequences shapes the transcription, translation and decay of mRNA [34] , particularly for RNA viruses. These determinants regulate the replication of pathogens in hosts via the machinery related to codon usage bias [29] [30] [31] [32] , the dinucleotide composition [19, 35] , tRNA abundance [31, 33] , mRNA decay [36] , the translation elongation speed [37] and translation efficiency [38] . Thus, the RNA sequence-based nucleotide composition is biologically meaningful and is closely related to the causal inference of virus phenotype. Family-, genus-, species-and even variant-specific determinants of the host adaptation of SARS-CoV-2 [9, 11] have been explored. Sporadic studies have described significant features of the CpG dinucleotides [39, 40] or codon usages [41] of SARS-CoV-2. Natural language processing methods have recently been shown to perform well in genomic sequence embedding [42, 43] , particularly in the identification of contextual meaning in viral genomes. DNA viruses are another group of viruses posing a potential threat to human population. It is not clear if adaptation also occurs in DNA virus genomes. However, the markedly lower diversity among DNA virus genes poses a challenge in the modulation of their adaptation space.

In response to questions about CoV adaptation, the present study focused on the identification of a general genomic trait of DCR at the viral RNA level in two major genes, Gp and RdRp, of ssRNA viruses. General separability and linearity of DCR and other compositional traits were shown among the six virus families. Interviridae separation and intraviridae clustering of Gp or RdRp samples were observed. The continuity and differentiability of these traits supported the potential of these for machine/deep learning classification [25] . A high linear distribution of each of these traits was also found for both genes among the six virus families, particularly in DCR. Moreover, we confirmed the assumed general adaptation of DCR and other compositional traits, with a strong Gp-RdRp correlation in DCR and a high representativeness value of DCR against any of the other four types of compositional traits. Thus, DCR played its role in genomic sequence embedding well, representing local contextual semantics to project genes in a nucleotide compositional space with the same vector length, with a higher sequence length comparability.

The current WHO nomenclature scheme, which is based on the use of significant AA substitutions to facilitate the risk assessment of SARS-CoV-2 variants, is hysteretic due to the monitoring period. As of June 2021, 43.11% of SARS-CoV-2 samples in GISAID were not labelled, although D614G, N501Y and other mutations were widely distributed among these variants. Based on biologically interpretable meaning, the DCR-based 3D-CNN predictor was promising for the prediction of CoV adaptation. The SARS-CoV-2-excluded training data, after intra-DCR-type convolution without inter-DCRtype convolution, clearly classified CoVs as showing inadaptation, type I or type II human adaptation, as validated by randomly sampled validation data. Surprisingly, 60.96% of SARS-CoV-2 variants recorded since December 2019 were predicted to show type II human adaptation, although SARS-CoV-2 is phylogenetically most closely related to SARS CoVs [6, 44] , which are defined as showing type I human adaptation. According to the WHO nomenclature scheme, SARS-CoV-2 VOCs pose a greater pandemic risk. Interestingly, the DCRbased 3D-CNN predictor recognized 67% of VOCs/VOIs (mainly Alpha and Kappa) as showing type I adaptation but recognized 91% VOIs and 95% of variants other than VOCs and VOIs as showing type II adaptation. According to our predictions, it is reasonable to deduce that SARS-CoV-2 VOCs present relatively higher pathogenicity, while most SARS-CoV-2 variants, SARS-CoV-2 VOIs and other variants exhibit typical 'common cold'-like CoV adaptation. Considering the obvious timeliness advantage, DCR-based 3D-CNN shows strong potential to assess the risk of any emerging variant with novel mutations in real time, without a monitoring period. Most variants with type I adaptation were found from January to April 2021 in Europe and America, whereas the variants with type II adaptation were distributed over a wider temporal and spatial range. Additionally, there was only a marginal probability advantage of these variants exhibiting type I human adaptation, while a markedly higher probability advantage was observed for type II adaptation. Taken together, the data indicate that the SARS-CoV-2 variant population is mainly characterized by higher transmissibility and lower pathogenicity than other 'common cold'-type CoVs. This model also predicted the most recent Omicron VOC to show type II adaptation, indicating potentially high transmissibility and low pathogenicity of this new VOC member.

In addition, since compositional DCR or DNT traits could not identify the specific determinant mutations contributing to type I or II adaptation, it was reasonable to perform a comparative analysis of different features of the two groups of variants. Dot products for each pair of DNT vectors at each nucleotide site identified the significantly different mutations D1118H, A570D, P681H, S982A, T716I and N501Y, implying their contribution to SARS-CoV-2 VOCs and other variants with type I adaptation. Such performance in discriminating key mutations and classifying SARS-CoV-2 variants based on the general CoV-adaptive DCR-based predictor is encouraging, as it implies the potential to assess the risk of emerging CoVs by predicting adaptation.

In summary, our study provides a strategy for parsing the general genomic traits of RNA viruses and accordingly building a deep-learning predictor to assess the risk of emerging viruses. The DCR-based 3D-CNN predictor provides real-time predictions of emerging SARS-CoV-2 variants, facilitating the risk assessment of SARS-CoV-2 variants and the control of the current COVID-19 pandemic.

Full sequences of six families/orders of RNA viruses were parsed from GenBank files with the script DCR_scripts. Data_parsing (https://github.com/Jamalijama/Dinucleo tide-Composition-Representation-DCR-) or randomly sampled from past influenza viruses (Orthomyxoviridae) [19, 45] . Detailed information on all six families of viruses involved in this study was provided under the environmental variable Surpporting_data_Full_DCR_6Viridae under the data of DCR_scripts. CoV coding sequences were labelled with host information of Primates, Chiroptera, Carnivora, Artiodactyla or the Suiformes suborder for viruses originating from humans, bats, canines/felines, bovines and other Artiodactyla [46] [47] [48] or swine, respectively. Sequence length filtering was performed with down and up thresholds of 27 000 and 32 000 bp, respectively. After sequence length filtering, sequences were counted for compositional DCR, DNT, AAs, codons and codon pairs for each sequence sample with the script DCR_scripts.DCR_counting_sampling. For each compositional trait, every type of feature was calculated as a frequency relative to the total. DNT and DCR were counted depending on each nucleotide in a codon. Each of the 16 types of DNTs [19] for nucleotide (nt) 1, 2 or 3 of a codon was counted as follows:

DCR methods were designed to embed contextual codon nucleotide-dependent DNTs into a compositional space as three types of paired DNTs at the meta position, with a starting site for the first DNT of 1, 2 or 3 in the codon, and the other three types of paired DNTs at the ortho position (one nucleotide apart). The former DCR set represented the tetranucleotide with its first nucleotide starting from codon site 1, 2 or 3. The last DCR set represented two pairs of DNTs starting at site 1 or 2 in two neighbouring codons and the bridge DNT of the two neighbouring codons. DCR was counted as a frequency value as follows: 

The general adaptation of the compositional traits in both CoV genes was evaluated to determine whether there was a similar feature distribution of a trait between the two genes. Thus, the reduced PCA1 values for both S and RdRp were plotted in pairs, with host information labelled for each data point. Spearman's correlation was used to quantify such adaptation, with five repeats of randomly sampled data. The representativeness of DCR for other traits was examined by linear regression for both RdRp and S genes based on the sampled data, with the script under the environment variable of Analysis/DCR_scripts. Analysis details are available at GitHub (https://github.com/Jamalijama/Dinucleotide-Composition-Representation-DCR-).

To avoid the inf luence of number-imbalance among sequence samples with different host labels, down-and up-sampling were performed with the Python scripts pandas. DataFrame.sample and python imblearn.over_ sampling.SMOTE, respectively. S samples of CoVs (excluding SARS-CoV-2) were randomly divided into a trainingset for supervised classifier training and a validationset for classification validation (test size = 0.3). SARS-CoV-2 S was subjected to adaptation prediction with the trained 3D CNN model. Both the training and validation data were reshaped into a (6, 16, 16) array with one channel. The 3D CNN was constructed with three layers of convolution calculations with 8, 16 and 32 out channels, with a stride of one and a padding of one. A 6 × 16 × 16 matrix was convoluted with a ReLU function into a f lattened vector of 768, which was activated with a sigmoid function and reduced to a vector of 192. Finally, the reduced vector was linearized into three predicted values, and adaptation was predicted with the function max (value 1, value 2, value 3) for the adaptation label set of inadaptation, type I adaptation and type II adaptation. For validation, the host with the greatest probability was considered the adaptation host. To validate the performance of the 3D-CNN, confusion matrices and micro-average ROC curves with AUCs were drawn [49, 50] . The detailed scripts are under the variables of 3D_CNN_training and 3D_CNN_predicting of DCR_scripts.

Sigmoid function :

ReLU function : f (x) = max 0, w T x + b

To assess the temporal and spatial adaptation of SARS-CoV-2 VOCs, VOIs and other variants, we extracted data on the collection year and month and continent information from the spatial labels of country and area. The S sequence number of SARS-CoV-2 samples with their predicted adaptation label (type I or II adaptation) was temporally and spatially plotted. The ratios of SARS-CoV-2 samples of VOCs/VOIs and total SARS-CoV-2 variants were also temporally plotted. A confusion matrix calculation was performed to compare the adaptation predictions (type I and II adaptation) to the WHO nomenclature of VOCs, VOIs and other variants. Greek alphabet variants with a predicted adaptation label were stack plotted with the ratio of variants showing type II adaptation to the total annotated variants. Statistics of probability were calculated for the two types of variant adaptation; the probability distribution was plotted for the two groups of samples in the sampling months of February 2020, August 2020 and April 2021.

To evaluate the specific DNT or amino acid differences between the type I and II adaptation groups, all SARS-CoV-2 S (Gp) cDNA sequences were transformed into DNT sequences according to a defined transformation table (Supplementary file 'DNT_transforming_dict.txt' available online at http://bib.oxfordjournals.org/) or were translated to AA sequences. For DNT sequences with 3821 DNTs (the last nucleotide was not transformed for a cDNA sequence with 3822 nts) or protein sequences with 1273 amino acids, each DNT/AA was calculated for each site for sequences with a label of type I or type II adaptation. A vector with serial 17 (16 types of DNTs and one deletion sign of '-') or 21 (20 types of DNTs and one deletion sign of '-'), count numbers were normalized with a normalization function as follows:

To compare the DNT or AA distribution at each site for the two groups of sequences, a dot product was calculated for each pair of 3821 DNT counting vectors or of 1273 amino acid counting vectors for the two groups of S sequences, and the product value was used as an index of vector similarity (DNT/AA distribution similarity). A logo plot of the top 23 significantly different DNTs was drawn using Logomaker [51] according to the DNT frequency. Significantly different AAs at the AA sites corresponding to the 23 DNT sites are also listed. The scripts are under the environmental variable DCR_scripts\Feature_importance.

• Six families of ssRNA viruses show general separability and linearity, and both the CoV spike and RdRp genes show host specificity according to DCR. • 3D CNNs based on DCR of the spike gene of other CoVs predict two types of human adaptation of SARS-CoV-2 variants. • Alpha SARS-CoV-2 VOCs present SARS-CoV-like human adaptation, while Delta, Beta and Omicron VOCs present 'common cold' CoV-like human adaptation.

Supplementary data are available online at https:// academic.oup.com/bib. in SARS-CoV-2 sequences; detailed sequence information is listed in the Supplementary Data available online at http://bib.oxfordjournals.org/.

J.L. conceived the study and performed model building. J.L., S.Z., Y.N.W. and X.P.K. collected data and performed data analysis. J.L. and T.J. supervised the project. J.L. wrote the manuscript with help from S.Z., Y.N.W. and T.J.

The full genomic sequences and other detailed information of three -ssRNA order/families of Bunyavirales and Filoviridae and three +ssRNA virus families Flaviviridae, Togaviridae and Coronaviridae available up to November 2019 were downloaded from the nucleotide database (https://www.ncbi.nlm.nih.gov/ nuccore). Orthomyxoviridae sequences of IAVs were downloaded from the Inf luenza Research Database (IRD) [45] . Coding sequences of Gp and RdRp were parsed by using Python scripts. SARS-CoV-2 sequences from December 2019 to June 2021 were downloaded from GISAID [52] ; audacity multiple sequence alignment (unmasked) (https://www.epicov.org/epi3/cfrontend); SARS-CoV-2S (Gp) was parsed with a fixed length of 3822 nts. Key scripts for nucleotide composition counting, data analysis, visualization and model training models that support the findings of this study have been deposited in GitHub (https://github.com/Jamalijama/Dinucleotide-Composition-Representation-DCR-).

Influenza virus evolution, host adaptation, and pandemic formation

Prisoners of warhost adaptation and its constraints on virus evolution

Origin and evolution of pathogenic coronaviruses

Human coronavirus: host-pathogen interaction

Human coronaviruses: a review of virus-host interactions

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Interplay between emerging SARS-CoV-2 variants and pandemic control

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Mutation D614G increases SARS-CoV-2 transmission

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19

Vaccine breakthrough infections with SARS-CoV-2 variants

Emerging vaccine-breakthrough SARS-CoV-2 variants

Addendum: a dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Structural impact on SARS-CoV-2 spike protein by D614G substitution

CompoDynamics: a comprehensive database for characterizing sequence composition dynamics

Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes

Machine learning methods for predicting human-adaptive influenza a viruses based on viral nucleotide compositions

Effective and scalable single-cell data alignment with non-linear canonical correlation analysis

Learning the language of viral evolution and escape

Unified rational protein engineering with sequence-based deep representation learning

Visualizing data using t-SNE

Principal component analysis: a review and recent developments

Review of machine learning methods in soft robotics

SARS-CoV-2 B.1.1.529 (Omicron) variant-United States

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

Prediction and evolution of the molecular fitness of SARS-CoV-2 variants: introducing SpikePro

Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies

A codon-based model of hostspecific selection in parasites, with an application to the influenza a virus

Codon usage bias and tRNA over-expression in Buchnera aphidicola after aromatic amino acid nutritional stress on its host Acyrthosiphon pisum

Viral adaptation to host: a proteome-based analysis of codon usage and amino acid preferences

Dissimilation of synonymous codon usage bias in virus-host coevolution due to translational selection

Central dogma rates and the trade-off between precision and economy in gene expression

CpG dinucleotide frequencies reveal the role of host methylation capabilities in parvovirus evolution

Characterisation of the Semliki Forest virus-host cell interactome reveals the viral capsid protein as an inhibitor of nonsense-mediated mRNA decay

Selection on codon bias

tRNA gene number and codon usage in the C. elegans genome are co-adapted for optimal translation of highly expressed genes

Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense

Viral CpG deficiency provides no evidence that dogs were intermediate hosts for SARS-CoV-2

Base composition and host adaptation of the SARS-CoV-2: insight from the codon usage perspective

Unified rational protein engineering with sequence-based deep representation learning

Evaluating protein transfer learning with TAPE

The proximal origin of SARS-CoV-2

Influenza research database: an integrated bioinformatics resource for influenza virus research

High sequence similarity within ras exons 1 and 2 in different mammalian species and phylogenetic divergence of the ras gene family

Replicative capacity of MERS coronavirus in livestock cell lines

Genetic detection and pathological finding of BVDV and BHV-1 in camel calves

Theoretical analysis of an alphabetic confusion matrix

An introduction to ROC analysis

Logomaker: beautiful sequence logos in python

disease and diplomacy: GISAID's innovative contributionto global health

We gratefully acknowledge the scientific community on the GISAID EpiCoV platform and all contributing experts